Literature DB >> 24133633

NF-κB inhibitor could be a novel treatment for multiple myeloma.

.   

Abstract

Entities:  

Year:  2012        PMID： 24133633      PMCID： PMC3727839          DOI： 10.1038/bonekey.2012.218

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN： 2047-6396


× No keyword cloud information.
  1 in total

1.  Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myeloma.

Authors:  Claire Fabre; Naoya Mimura; Kathryn Bobb; Sun-Young Kong; Güllü Gorgun; Diana Cirstea; Yiguo Hu; Jiro Minami; Hiroto Ohguchi; Jie Zhang; Jeffrey Meshulam; Ruben D Carrasco; Yu-Tzu Tai; Paul G Richardson; Teru Hideshima; Kenneth C Anderson
Journal:  Clin Cancer Res       Date:  2012-07-17       Impact factor: 12.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.